title: Mechanism-based inhibition of mouse P4502b-10 by selected arylalkynes.
abstract: Suicide inhibitors of cytochrome P450 families are excellent tools to predict which isoforms mediate the metabolism/activation of a variety of chemical agents. We compared the inhibitory effects of several arylalkynes on mouse cytochromes P450 with published data for the rat model. The inhibition of P4502b specific dealkylation of benzyloxyresorufin by 2-ethynylnaphthalene (2-EN), 5-phenyl-1-pentyne (PPY), 4-phenyl-1-butyne (PBY), and 9-ethynylphenanthrene (9-EPh) was measured in hepatic microsomes from male mice treated with 1,4-bis[2-(3,5-dichloropyridyloxy)]-benzene (TCPOBOP) to induce cytochrome P4502b. Pulmonary microsomes were prepared from untreated mice. 9-EPh, 2-EN, and PPY caused a time-, concentration-, and NADPH-dependent loss in P4502b activity in both tissues. PBY, however, demonstrated this type of inhibition only in liver microsomes. The IC50 was calculated for both liver and lung microsomes and compared with published Ki (concentration required for half-maximal inhibition) or KI (concentration required for half-maximal inactivation) values for the rat. PPY, PBY, and 9-EPh were equally effective inhibitors of mouse P4502b and rat P4502B1. 2-EN was a 5- to 10-fold less potent inhibitor of mouse P4502b, as compared with the rat, even though it was shown to bind to the active site of the mouse isoform as demonstrated by its metabolism to 2-naphthylacetic acid. These data suggest that the active site of the mouse P4502b enzyme is functionally similar to the rat P4502B isoform, with the exception of the disparity in its susceptibility to inactivation by 2-EN as measured by the Ki values.
authors.affiliation: Laboratory of Comparative Carcinogenesis, NCI-FCRDC, Frederick, MD 21702, USA.
authors.forename: L E
authors.initials: LE
authors.lastname: Beebe
authors.forename: E S
authors.initials: ES
authors.lastname: Roberts
authors.forename: L W
authors.initials: LW
authors.lastname: Fornwald
authors.forename: P F
authors.initials: PF
authors.lastname: Hollenberg
authors.forename: W L
authors.initials: WL
authors.lastname: Alworth
mesh_terms: D000480:Alkynes / Q000494:pharmacology*; D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D000072467:Cytochrome P450 Family 2; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D066298:In Vitro Techniques; D007700:Kinetics; D008168:Lung / Q000201:enzymology; D008297:Male; D051379:Mice; D008861:Microsomes / Q000201:enzymology; D008862:Microsomes, Liver / Q000201:enzymology; D009281:Naphthalenes / Q000494:pharmacology; D010078:Oxazines / Q000378:metabolism; D010616:Phenanthrenes / Q000494:pharmacology; D051381:Rats; D013250:Steroid Hydroxylases
chemical_list: C096666:9-ethynylphenanthrene; D000480:Alkynes; D065607:Cytochrome P-450 Enzyme Inhibitors; D004791:Enzyme Inhibitors; D009281:Naphthalenes; D010078:Oxazines; D010616:Phenanthrenes; C065012:2-ethynylnaphthalene; C057754:benzyloxyresorufin; D003577:Cytochrome P-450 Enzyme System; D013250:Steroid Hydroxylases; D001189:Aryl Hydrocarbon Hydroxylases; C101679:Cyp2b10 protein, mouse; D000072467:Cytochrome P450 Family 2